Immunomodulators are used for the management of severe asthma refractory to a combination of step-up asthma therapies, usually high-dose inhaled corticosteroids with a long-acting beta2-adrenergic receptor agonist, and primarily characterized by elevated allergic inflammation biomarkers (serum IgE, blood eosinophil count).